Flow cytometry is a major tool for basic research in immunology, molecular and cell biology, and genetics. It has been widely used by immunologists to investigate lymphocyte development and function and by cell biologists to study calcium mobilization, cell cycle and to sort cells based on cell surface markers. With the advancement of new reporter genes such as green fluorescent protein (GFP), flow cytometry has also become a major research tool for molecular biologists in investigating gene expression and to mark and sort expressing cells. Research generated from using flow cytometers has advanced our understanding in basic biological processes, infectious diseases and cancer. The MIT CCR has operated the Flow Cytometry Core Facility since 1987. Its mission is threefold: (1) to provide CCR Investigators and their laboratories with access to cutting-edge methods in flow cytometry, in the form of both assisted and unassisted cell sorting, by maintaining state of the art instrumentation, along with the technical and intellectual expertise necessary to operate it, in one location;(2) to offer state-of-the-art training in the use and maintenance of cell sorting instrumentation to all CCR researchers;and (3) to provide a source of expertise on experimental design, reagent selection and data analysis and interpretation through interactions with facility staff. Price comparisons show that the cost of services to CCR Investigators is highly competitive with those charged by other academic or commercial flow cytometry facilities both within the Boston/Cambridge area and nationwide.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014051-38
Application #
7849615
Study Section
Project Start
Project End
Budget Start
2009-05-01
Budget End
2010-04-30
Support Year
38
Fiscal Year
2009
Total Cost
$286,944
Indirect Cost
Name
Massachusetts Institute of Technology
Department
Type
DUNS #
001425594
City
Cambridge
State
MA
Country
United States
Zip Code
02139
Tentori, Augusto M; Nagarajan, Maxwell B; Kim, Jae Jung et al. (2018) Quantitative and multiplex microRNA assays from unprocessed cells in isolated nanoliter well arrays. Lab Chip 18:2410-2424
Parisi, Tiziana; Balsamo, Michele; Gertler, Frank et al. (2018) The Rb tumor suppressor regulates epithelial cell migration and polarity. Mol Carcinog 57:1640-1650
Gam, Jeremy J; Babb, Jonathan; Weiss, Ron (2018) A mixed antagonistic/synergistic miRNA repression model enables accurate predictions of multi-input miRNA sensor activity. Nat Commun 9:2430
Chen, Huihui; Cho, Kin-Sang; Vu, T H Khanh et al. (2018) Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma. Nat Commun 9:3209
Tam, Brooke E; Hao, Yining; Sikes, Hadley D (2018) An examination of critical parameters in hybridization-based epigenotyping using magnetic microparticles. Biotechnol Prog 34:1589-1595
Ramadi, Khalil B; Dagdeviren, Canan; Spencer, Kevin C et al. (2018) Focal, remote-controlled, chronic chemical modulation of brain microstructures. Proc Natl Acad Sci U S A 115:7254-7259
Knouse, Kristin A; Lopez, Kristina E; Bachofner, Marc et al. (2018) Chromosome Segregation Fidelity in Epithelia Requires Tissue Architecture. Cell 175:200-211.e13
Sabari, Benjamin R; Dall'Agnese, Alessandra; Boija, Ann et al. (2018) Coactivator condensation at super-enhancers links phase separation and gene control. Science 361:
Clancy-Thompson, Eleanor; Devlin, Christine A; Tyler, Paul M et al. (2018) Altered Binding of Tumor Antigenic Peptides to MHC Class I Affects CD8+ T Cell-Effector Responses. Cancer Immunol Res 6:1524-1536
Fiedler, Eleanor R C; Bhutkar, Arjun; Lawler, Emily et al. (2018) In vivo RNAi screening identifies Pafah1b3 as a target for combination therapy with TKIs in BCR-ABL1 + BCP-ALL. Blood Adv 2:1229-1242

Showing the most recent 10 out of 904 publications